 | • レポートコード：MRC2-11QY08098 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はナイセリア淋菌感染症治療のグローバル市場について調査・分析したレポートです。種類別（クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ナイセリア淋菌感染症治療の競争状況、市場シェア ・世界のナイセリア淋菌感染症治療市場：種類別市場規模 2015年-2020年（クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他） ・世界のナイセリア淋菌感染症治療市場：種類別市場規模予測 2021年-2026年（クリブロスタチン-6、ダルババンシン、デビオ-1453、メシル酸ゲポチダシン、その他） ・世界のナイセリア淋菌感染症治療市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界のナイセリア淋菌感染症治療市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米のナイセリア淋菌感染症治療市場分析：米国、カナダ ・ヨーロッパのナイセリア淋菌感染症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのナイセリア淋菌感染症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のナイセリア淋菌感染症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのナイセリア淋菌感染症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan Plc、BioDiem Ltd、Biolytics Pharma、Debiopharm International SA、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline Plc、Merck & Co., Inc.、Paratek Pharmaceuticals, Inc.、Recce Pty Ltd、Redx Pharma Plc、Sarepta Therapeutics, Inc.、Sumitomo Dainippon Pharma Co., Ltd. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Neisseria Gonorrhoeae Infections Treatment Market
The global Neisseria Gonorrhoeae Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Neisseria Gonorrhoeae Infections Treatment Scope and Market Size
Neisseria Gonorrhoeae Infections Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neisseria Gonorrhoeae Infections Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Neisseria Gonorrhoeae Infections Treatment market is segmented into
Cribrostatin-6
Dalbavancin
Debio-1453
Gepotidacin Mesylate
Others
Segment by Application, the Neisseria Gonorrhoeae Infections Treatment market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Neisseria Gonorrhoeae Infections Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Neisseria Gonorrhoeae Infections Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Neisseria Gonorrhoeae Infections Treatment Market Share Analysis
Neisseria Gonorrhoeae Infections Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neisseria Gonorrhoeae Infections Treatment business, the date to enter into the Neisseria Gonorrhoeae Infections Treatment market, Neisseria Gonorrhoeae Infections Treatment product introduction, recent developments, etc.
The major vendors covered:
Allergan Plc
BioDiem Ltd
Biolytics Pharma
Debiopharm International SA
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Merck & Co., Inc.
Paratek Pharmaceuticals, Inc.
Recce Pty Ltd
Redx Pharma Plc
Sarepta Therapeutics, Inc.
Sumitomo Dainippon Pharma Co., Ltd.
1 Study Coverage
1.1 Neisseria Gonorrhoeae Infections Treatment Product Introduction
1.2 Market Segments
1.3 Key Neisseria Gonorrhoeae Infections Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Neisseria Gonorrhoeae Infections Treatment Market Size Growth Rate by Type
1.4.2 Cribrostatin-6
1.4.3 Dalbavancin
1.4.4 Debio-1453
1.4.5 Gepotidacin Mesylate
1.4.6 Others
1.5 Market by Application
1.5.1 Global Neisseria Gonorrhoeae Infections Treatment Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Neisseria Gonorrhoeae Infections Treatment Market Size, Estimates and Forecasts
2.1.1 Global Neisseria Gonorrhoeae Infections Treatment Revenue 2015-2026
2.1.2 Global Neisseria Gonorrhoeae Infections Treatment Sales 2015-2026
2.2 Global Neisseria Gonorrhoeae Infections Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Neisseria Gonorrhoeae Infections Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Neisseria Gonorrhoeae Infections Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Neisseria Gonorrhoeae Infections Treatment Competitor Landscape by Players
3.1 Neisseria Gonorrhoeae Infections Treatment Sales by Manufacturers
3.1.1 Neisseria Gonorrhoeae Infections Treatment Sales by Manufacturers (2015-2020)
3.1.2 Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Neisseria Gonorrhoeae Infections Treatment Revenue by Manufacturers
3.2.1 Neisseria Gonorrhoeae Infections Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Neisseria Gonorrhoeae Infections Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Neisseria Gonorrhoeae Infections Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Neisseria Gonorrhoeae Infections Treatment Revenue in 2019
3.2.5 Global Neisseria Gonorrhoeae Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Neisseria Gonorrhoeae Infections Treatment Price by Manufacturers
3.4 Neisseria Gonorrhoeae Infections Treatment Manufacturing Base Distribution, Product Types
3.4.1 Neisseria Gonorrhoeae Infections Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neisseria Gonorrhoeae Infections Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Neisseria Gonorrhoeae Infections Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Neisseria Gonorrhoeae Infections Treatment Market Size by Type (2015-2020)
4.1.1 Global Neisseria Gonorrhoeae Infections Treatment Sales by Type (2015-2020)
4.1.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue by Type (2015-2020)
4.1.3 Neisseria Gonorrhoeae Infections Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Neisseria Gonorrhoeae Infections Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Neisseria Gonorrhoeae Infections Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Neisseria Gonorrhoeae Infections Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Neisseria Gonorrhoeae Infections Treatment Market Size by Application (2015-2020)
5.1.1 Global Neisseria Gonorrhoeae Infections Treatment Sales by Application (2015-2020)
5.1.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue by Application (2015-2020)
5.1.3 Neisseria Gonorrhoeae Infections Treatment Price by Application (2015-2020)
5.2 Neisseria Gonorrhoeae Infections Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Neisseria Gonorrhoeae Infections Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Neisseria Gonorrhoeae Infections Treatment by Country
6.1.1 North America Neisseria Gonorrhoeae Infections Treatment Sales by Country
6.1.2 North America Neisseria Gonorrhoeae Infections Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Neisseria Gonorrhoeae Infections Treatment Market Facts & Figures by Type
6.3 North America Neisseria Gonorrhoeae Infections Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Neisseria Gonorrhoeae Infections Treatment by Country
7.1.1 Europe Neisseria Gonorrhoeae Infections Treatment Sales by Country
7.1.2 Europe Neisseria Gonorrhoeae Infections Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neisseria Gonorrhoeae Infections Treatment Market Facts & Figures by Type
7.3 Europe Neisseria Gonorrhoeae Infections Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Neisseria Gonorrhoeae Infections Treatment by Region
8.1.1 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Sales by Region
8.1.2 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Market Facts & Figures by Type
8.3 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Neisseria Gonorrhoeae Infections Treatment by Country
9.1.1 Latin America Neisseria Gonorrhoeae Infections Treatment Sales by Country
9.1.2 Latin America Neisseria Gonorrhoeae Infections Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Neisseria Gonorrhoeae Infections Treatment Market Facts & Figures by Type
9.3 Central & South America Neisseria Gonorrhoeae Infections Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Neisseria Gonorrhoeae Infections Treatment by Country
10.1.1 Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Sales by Country
10.1.2 Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Corporation Information
11.1.2 Allergan Plc Description and Business Overview
11.1.3 Allergan Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Products Offered
11.1.5 Allergan Plc Related Developments
11.2 BioDiem Ltd
11.2.1 BioDiem Ltd Corporation Information
11.2.2 BioDiem Ltd Description and Business Overview
11.2.3 BioDiem Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Products Offered
11.2.5 BioDiem Ltd Related Developments
11.3 Biolytics Pharma
11.3.1 Biolytics Pharma Corporation Information
11.3.2 Biolytics Pharma Description and Business Overview
11.3.3 Biolytics Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Products Offered
11.3.5 Biolytics Pharma Related Developments
11.4 Debiopharm International SA
11.4.1 Debiopharm International SA Corporation Information
11.4.2 Debiopharm International SA Description and Business Overview
11.4.3 Debiopharm International SA Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Products Offered
11.4.5 Debiopharm International SA Related Developments
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.5.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Products Offered
11.5.5 F. Hoffmann-La Roche Ltd. Related Developments
11.6 GlaxoSmithKline Plc
11.6.1 GlaxoSmithKline Plc Corporation Information
11.6.2 GlaxoSmithKline Plc Description and Business Overview
11.6.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Products Offered
11.6.5 GlaxoSmithKline Plc Related Developments
11.7 Merck & Co., Inc.
11.7.1 Merck & Co., Inc. Corporation Information
11.7.2 Merck & Co., Inc. Description and Business Overview
11.7.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Products Offered
11.7.5 Merck & Co., Inc. Related Developments
11.8 Paratek Pharmaceuticals, Inc.
11.8.1 Paratek Pharmaceuticals, Inc. Corporation Information
11.8.2 Paratek Pharmaceuticals, Inc. Description and Business Overview
11.8.3 Paratek Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Products Offered
11.8.5 Paratek Pharmaceuticals, Inc. Related Developments
11.9 Recce Pty Ltd
11.9.1 Recce Pty Ltd Corporation Information
11.9.2 Recce Pty Ltd Description and Business Overview
11.9.3 Recce Pty Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Products Offered
11.9.5 Recce Pty Ltd Related Developments
11.10 Redx Pharma Plc
11.10.1 Redx Pharma Plc Corporation Information
11.10.2 Redx Pharma Plc Description and Business Overview
11.10.3 Redx Pharma Plc Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Products Offered
11.10.5 Redx Pharma Plc Related Developments
11.1 Allergan Plc
11.1.1 Allergan Plc Corporation Information
11.1.2 Allergan Plc Description and Business Overview
11.1.3 Allergan Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Products Offered
11.1.5 Allergan Plc Related Developments
11.12 Sumitomo Dainippon Pharma Co., Ltd.
11.12.1 Sumitomo Dainippon Pharma Co., Ltd. Corporation Information
11.12.2 Sumitomo Dainippon Pharma Co., Ltd. Description and Business Overview
11.12.3 Sumitomo Dainippon Pharma Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Sumitomo Dainippon Pharma Co., Ltd. Products Offered
11.12.5 Sumitomo Dainippon Pharma Co., Ltd. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Neisseria Gonorrhoeae Infections Treatment Market Estimates and Projections by Region
12.1.1 Global Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Neisseria Gonorrhoeae Infections Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Neisseria Gonorrhoeae Infections Treatment Sales Forecast (2021-2026)
12.2.2 North America: Neisseria Gonorrhoeae Infections Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Neisseria Gonorrhoeae Infections Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Neisseria Gonorrhoeae Infections Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Neisseria Gonorrhoeae Infections Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Neisseria Gonorrhoeae Infections Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Neisseria Gonorrhoeae Infections Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Neisseria Gonorrhoeae Infections Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Neisseria Gonorrhoeae Infections Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Neisseria Gonorrhoeae Infections Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Neisseria Gonorrhoeae Infections Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Neisseria Gonorrhoeae Infections Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Neisseria Gonorrhoeae Infections Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Neisseria Gonorrhoeae Infections Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Neisseria Gonorrhoeae Infections Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Neisseria Gonorrhoeae Infections Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Neisseria Gonorrhoeae Infections Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Neisseria Gonorrhoeae Infections Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neisseria Gonorrhoeae Infections Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Neisseria Gonorrhoeae Infections Treatment Market Segments
Table 2. Ranking of Global Top Neisseria Gonorrhoeae Infections Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Neisseria Gonorrhoeae Infections Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Cribrostatin-6
Table 5. Major Manufacturers of Dalbavancin
Table 6. Major Manufacturers of Debio-1453
Table 7. Major Manufacturers of Gepotidacin Mesylate
Table 8. Major Manufacturers of Others
Table 9. Global Neisseria Gonorrhoeae Infections Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Neisseria Gonorrhoeae Infections Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Neisseria Gonorrhoeae Infections Treatment Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Regions (2015-2020)
Table 13. Global Neisseria Gonorrhoeae Infections Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Neisseria Gonorrhoeae Infections Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Neisseria Gonorrhoeae Infections Treatment Sales Share by Manufacturers (2015-2020)
Table 16. Global Neisseria Gonorrhoeae Infections Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Neisseria Gonorrhoeae Infections Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neisseria Gonorrhoeae Infections Treatment as of 2019)
Table 18. Neisseria Gonorrhoeae Infections Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Neisseria Gonorrhoeae Infections Treatment Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Neisseria Gonorrhoeae Infections Treatment Price (2015-2020) (USD/Pcs)
Table 21. Neisseria Gonorrhoeae Infections Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Neisseria Gonorrhoeae Infections Treatment Product Type
Table 23. Date of International Manufacturers Enter into Neisseria Gonorrhoeae Infections Treatment Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Neisseria Gonorrhoeae Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 26. Global Neisseria Gonorrhoeae Infections Treatment Sales Share by Type (2015-2020)
Table 27. Global Neisseria Gonorrhoeae Infections Treatment Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Neisseria Gonorrhoeae Infections Treatment Revenue Share by Type (2015-2020)
Table 29. Neisseria Gonorrhoeae Infections Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Neisseria Gonorrhoeae Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 31. Global Neisseria Gonorrhoeae Infections Treatment Sales Share by Application (2015-2020)
Table 32. North America Neisseria Gonorrhoeae Infections Treatment Sales by Country (2015-2020) (K Pcs)
Table 33. North America Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Country (2015-2020)
Table 34. North America Neisseria Gonorrhoeae Infections Treatment Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Country (2015-2020)
Table 36. North America Neisseria Gonorrhoeae Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 37. North America Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Type (2015-2020)
Table 38. North America Neisseria Gonorrhoeae Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 39. North America Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Application (2015-2020)
Table 40. Europe Neisseria Gonorrhoeae Infections Treatment Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Country (2015-2020)
Table 42. Europe Neisseria Gonorrhoeae Infections Treatment Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Country (2015-2020)
Table 44. Europe Neisseria Gonorrhoeae Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Type (2015-2020)
Table 46. Europe Neisseria Gonorrhoeae Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Application (2015-2020)
Table 56. Latin America Neisseria Gonorrhoeae Infections Treatment Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Neisseria Gonorrhoeae Infections Treatment Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Country (2015-2020)
Table 60. Latin America Neisseria Gonorrhoeae Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Type (2015-2020)
Table 62. Latin America Neisseria Gonorrhoeae Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Application (2015-2020)
Table 72. Allergan Plc Corporation Information
Table 73. Allergan Plc Description and Major Businesses
Table 74. Allergan Plc Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Allergan Plc Product
Table 76. Allergan Plc Recent Development
Table 77. BioDiem Ltd Corporation Information
Table 78. BioDiem Ltd Description and Major Businesses
Table 79. BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. BioDiem Ltd Product
Table 81. BioDiem Ltd Recent Development
Table 82. Biolytics Pharma Corporation Information
Table 83. Biolytics Pharma Description and Major Businesses
Table 84. Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Biolytics Pharma Product
Table 86. Biolytics Pharma Recent Development
Table 87. Debiopharm International SA Corporation Information
Table 88. Debiopharm International SA Description and Major Businesses
Table 89. Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Debiopharm International SA Product
Table 91. Debiopharm International SA Recent Development
Table 92. F. Hoffmann-La Roche Ltd. Corporation Information
Table 93. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 94. F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. F. Hoffmann-La Roche Ltd. Product
Table 96. F. Hoffmann-La Roche Ltd. Recent Development
Table 97. GlaxoSmithKline Plc Corporation Information
Table 98. GlaxoSmithKline Plc Description and Major Businesses
Table 99. GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. GlaxoSmithKline Plc Product
Table 101. GlaxoSmithKline Plc Recent Development
Table 102. Merck & Co., Inc. Corporation Information
Table 103. Merck & Co., Inc. Description and Major Businesses
Table 104. Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Merck & Co., Inc. Product
Table 106. Merck & Co., Inc. Recent Development
Table 107. Paratek Pharmaceuticals, Inc. Corporation Information
Table 108. Paratek Pharmaceuticals, Inc. Description and Major Businesses
Table 109. Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Paratek Pharmaceuticals, Inc. Product
Table 111. Paratek Pharmaceuticals, Inc. Recent Development
Table 112. Recce Pty Ltd Corporation Information
Table 113. Recce Pty Ltd Description and Major Businesses
Table 114. Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Recce Pty Ltd Product
Table 116. Recce Pty Ltd Recent Development
Table 117. Redx Pharma Plc Corporation Information
Table 118. Redx Pharma Plc Description and Major Businesses
Table 119. Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Redx Pharma Plc Product
Table 121. Redx Pharma Plc Recent Development
Table 122. Sarepta Therapeutics, Inc. Corporation Information
Table 123. Sarepta Therapeutics, Inc. Description and Major Businesses
Table 124. Sarepta Therapeutics, Inc. Neisseria Gonorrhoeae Infections Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Sarepta Therapeutics, Inc. Product
Table 126. Sarepta Therapeutics, Inc. Recent Development
Table 127. Sumitomo Dainippon Pharma Co., Ltd. Corporation Information
Table 128. Sumitomo Dainippon Pharma Co., Ltd. Description and Major Businesses
Table 129. Sumitomo Dainippon Pharma Co., Ltd. Neisseria Gonorrhoeae Infections Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Sumitomo Dainippon Pharma Co., Ltd. Product
Table 131. Sumitomo Dainippon Pharma Co., Ltd. Recent Development
Table 132. Global Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Regions (2021-2026) (K Pcs)
Table 133. Global Neisseria Gonorrhoeae Infections Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 134. Global Neisseria Gonorrhoeae Infections Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 135. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 136. North America: Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 137. North America: Neisseria Gonorrhoeae Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Europe: Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 139. Europe: Neisseria Gonorrhoeae Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Asia Pacific: Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 141. Asia Pacific: Neisseria Gonorrhoeae Infections Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 142. Latin America: Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 143. Latin America: Neisseria Gonorrhoeae Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Middle East and Africa: Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 145. Middle East and Africa: Neisseria Gonorrhoeae Infections Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 147. Key Challenges
Table 148. Market Risks
Table 149. Main Points Interviewed from Key Neisseria Gonorrhoeae Infections Treatment Players
Table 150. Neisseria Gonorrhoeae Infections Treatment Customers List
Table 151. Neisseria Gonorrhoeae Infections Treatment Distributors List
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Neisseria Gonorrhoeae Infections Treatment Product Picture
Figure 2. Global Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Cribrostatin-6 Product Picture
Figure 4. Dalbavancin Product Picture
Figure 5. Debio-1453 Product Picture
Figure 6. Gepotidacin Mesylate Product Picture
Figure 7. Others Product Picture
Figure 8. Global Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Neisseria Gonorrhoeae Infections Treatment Report Years Considered
Figure 13. Global Neisseria Gonorrhoeae Infections Treatment Market Size 2015-2026 (US$ Million)
Figure 14. Global Neisseria Gonorrhoeae Infections Treatment Sales 2015-2026 (K Pcs)
Figure 15. Global Neisseria Gonorrhoeae Infections Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Region (2015-2020)
Figure 17. Global Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Region in 2019
Figure 18. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Region (2015-2020)
Figure 19. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Region in 2019
Figure 20. Global Neisseria Gonorrhoeae Infections Treatment Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Neisseria Gonorrhoeae Infections Treatment Revenue in 2019
Figure 22. Neisseria Gonorrhoeae Infections Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Type (2015-2020)
Figure 24. Global Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Type in 2019
Figure 25. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Type (2015-2020)
Figure 26. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Type in 2019
Figure 27. Global Neisseria Gonorrhoeae Infections Treatment Market Share by Price Range (2015-2020)
Figure 28. Global Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Application (2015-2020)
Figure 29. Global Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Application in 2019
Figure 30. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Application (2015-2020)
Figure 31. Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Application in 2019
Figure 32. North America Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Country in 2019
Figure 35. North America Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Country in 2019
Figure 36. U.S. Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Neisseria Gonorrhoeae Infections Treatment Market Share by Type in 2019
Figure 41. North America Neisseria Gonorrhoeae Infections Treatment Market Share by Application in 2019
Figure 42. Europe Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Country in 2019
Figure 45. Europe Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Country in 2019
Figure 46. Germany Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Neisseria Gonorrhoeae Infections Treatment Market Share by Type in 2019
Figure 57. Europe Neisseria Gonorrhoeae Infections Treatment Market Share by Application in 2019
Figure 58. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Region in 2019
Figure 61. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Region in 2019
Figure 62. China Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Market Share by Type in 2019
Figure 85. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Market Share by Application in 2019
Figure 86. Latin America Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Country in 2019
Figure 89. Latin America Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Country in 2019
Figure 90. Mexico Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Neisseria Gonorrhoeae Infections Treatment Market Share by Type in 2019
Figure 97. Latin America Neisseria Gonorrhoeae Infections Treatment Market Share by Application in 2019
Figure 98. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Country in 2019
Figure 102. Turkey Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Market Share by Type in 2019
Figure 109. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Market Share by Application in 2019
Figure 110. North America Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
髄膜炎菌感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Neisseria meningitidis Infections Drug Market The global Neisseria meningitidis Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Neisseria meningitidis Infections Dru…- 壊死性皮膚感染症治療の世界市場（～2026年） Necrotizing skin infections ranks among the most rarely found diseases but are highly lethal infection. Necrotizing skin infection arise primarily in any layer of skin soft tissue such as dermis and epidermis that are associated with necrotizing changes. Necrotizing skin infection is also commonly c…
- 目感染症治療の世界市場（～2026年） Eye infections can be the inflammation of the Conjunctiva (Conjunctivitis), eyelid (blepharitis), the cornea (keratitis), the liquid inside the eye (vitritis), the retina and the blood vessels that feed it (chorioretinitis), or the optic nerve (neuroretinitis). Eye infections treatment market is gro…
- 人工関節感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Prosthetic Joint Infections Treatment Market The global Prosthetic Joint Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prosthetic Joint Infections Treatment S…
- エプスタインバーウイルス（HHV-4）感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Epstein-Barr Virus (HHV-4) Infections Treatment Market The global Epstein-Barr Virus (HHV-4) Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Epstein-Barr Virus …